Style | Citing Format |
---|---|
MLA | Khezeli Z, et al.. "The Lineage and Sublineage Investigation of Human Papillomavirus Type 16 in Tehran, Iran, During 2022–2023: A Cross-Sectional Study." Health Science Reports, vol. 8, no. 5, 2025, pp. -. |
APA | Khezeli Z, Shoja Z, Kaffashian M, Soleimanijelodar R, Jalilvand S (2025). The Lineage and Sublineage Investigation of Human Papillomavirus Type 16 in Tehran, Iran, During 2022–2023: A Cross-Sectional Study. Health Science Reports, 8(5), -. |
Chicago | Khezeli Z, Shoja Z, Kaffashian M, Soleimanijelodar R, Jalilvand S. "The Lineage and Sublineage Investigation of Human Papillomavirus Type 16 in Tehran, Iran, During 2022–2023: A Cross-Sectional Study." Health Science Reports 8, no. 5 (2025): -. |
Harvard | Khezeli Z et al. (2025) 'The Lineage and Sublineage Investigation of Human Papillomavirus Type 16 in Tehran, Iran, During 2022–2023: A Cross-Sectional Study', Health Science Reports, 8(5), pp. -. |
Vancouver | Khezeli Z, Shoja Z, Kaffashian M, Soleimanijelodar R, Jalilvand S. The Lineage and Sublineage Investigation of Human Papillomavirus Type 16 in Tehran, Iran, During 2022–2023: A Cross-Sectional Study. Health Science Reports. 2025;8(5):-. |
BibTex | @article{ author = {Khezeli Z and Shoja Z and Kaffashian M and Soleimanijelodar R and Jalilvand S}, title = {The Lineage and Sublineage Investigation of Human Papillomavirus Type 16 in Tehran, Iran, During 2022–2023: A Cross-Sectional Study}, journal = {Health Science Reports}, volume = {8}, number = {5}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Khezeli Z AU - Shoja Z AU - Kaffashian M AU - Soleimanijelodar R AU - Jalilvand S TI - The Lineage and Sublineage Investigation of Human Papillomavirus Type 16 in Tehran, Iran, During 2022–2023: A Cross-Sectional Study JO - Health Science Reports VL - 8 IS - 5 SP - EP - PY - 2025 ER - |